Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C van Rossum

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Journal of Neuroimmunology|January 6, 2018
Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniaePatrick M Meyer Sauteur, Ruth Huizinga, Anne P Tio-Gillen, et al.
Antiviral Therapy|August 20, 2003
Pharmacokinetics of nelfinavir in children: influencing factors and dose implicationsAlina S Bergshoeff, Pieter L A Fraaij, Annemarie M C van Rossum, et al.
The Journal of Infectious Diseases|February 20, 2014
Evidence for influenza virus CNS invasion along the olfactory route in an immunocompromised infantDebby van Riel, Lonneke M Leijten, Rob M Verdijk, et al.
Journal of Clinical Microbiology|April 13, 2012
Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The NetherlandsEmiel B M Spuesens, Adam Meijer, Damien Bierschenk, et al.
Pathogens (Basel, Switzerland)|May 27, 2023
Galacto-Oligosaccharides as an Anti-Infective and Anti-Microbial Agent for Macrolide-Resistant and -Sensitive <i>Mycoplasma pneumoniae</i>Hongzhen Zhu, Yang Cai, Lisa J M Slimmen, et al.
Journal of the Peripheral Nervous System : JPNS|June 27, 2015
Severe childhood Guillain-Barré syndrome associated with Mycoplasma pneumoniae infection: a case seriesPatrick M Meyer Sauteur, Joyce Roodbol, Annette Hackenberg, et al.
British Journal of Clinical Pharmacology|January 13, 2017
Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysisEsther J H Janssen, Diane E T Bastiaans, Pyry A J Välitalo, et al.
Plos One|March 11, 2016
Viruses as Sole Causative Agents of Severe Acute Respiratory Tract Infections in ChildrenFleur M Moesker, Jeroen J A van Kampen, Annemarie M C van Rossum, et al.
Antiviral Therapy|May 12, 2004
Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected childrenPieter L A Fraaij, Jennifer Neubert, Alina S Bergshoeff, et al.
Journal of the Peripheral Nervous System : JPNS|November 10, 2017
Antibody responses to GalC in severe and complicated childhood Guillain-Barré syndromePatrick M Meyer Sauteur, Ruth Huizinga, Anne P Tio-Gillen, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Journal of Neuroimmunology|January 6, 2018
Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniaePatrick M Meyer Sauteur, Ruth Huizinga, Anne P Tio-Gillen, et al.
Antiviral Therapy|August 20, 2003
Pharmacokinetics of nelfinavir in children: influencing factors and dose implicationsAlina S Bergshoeff, Pieter L A Fraaij, Annemarie M C van Rossum, et al.
The Journal of Infectious Diseases|February 20, 2014
Evidence for influenza virus CNS invasion along the olfactory route in an immunocompromised infantDebby van Riel, Lonneke M Leijten, Rob M Verdijk, et al.
Journal of Clinical Microbiology|April 13, 2012
Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The NetherlandsEmiel B M Spuesens, Adam Meijer, Damien Bierschenk, et al.
Pathogens (Basel, Switzerland)|May 27, 2023
Galacto-Oligosaccharides as an Anti-Infective and Anti-Microbial Agent for Macrolide-Resistant and -Sensitive <i>Mycoplasma pneumoniae</i>Hongzhen Zhu, Yang Cai, Lisa J M Slimmen, et al.
Journal of the Peripheral Nervous System : JPNS|June 27, 2015
Severe childhood Guillain-Barré syndrome associated with Mycoplasma pneumoniae infection: a case seriesPatrick M Meyer Sauteur, Joyce Roodbol, Annette Hackenberg, et al.
British Journal of Clinical Pharmacology|January 13, 2017
Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysisEsther J H Janssen, Diane E T Bastiaans, Pyry A J Välitalo, et al.
Plos One|March 11, 2016
Viruses as Sole Causative Agents of Severe Acute Respiratory Tract Infections in ChildrenFleur M Moesker, Jeroen J A van Kampen, Annemarie M C van Rossum, et al.
Antiviral Therapy|May 12, 2004
Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected childrenPieter L A Fraaij, Jennifer Neubert, Alina S Bergshoeff, et al.
Journal of the Peripheral Nervous System : JPNS|November 10, 2017
Antibody responses to GalC in severe and complicated childhood Guillain-Barré syndromePatrick M Meyer Sauteur, Ruth Huizinga, Anne P Tio-Gillen, et al.
Pageof 12